RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial (Q65475052)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial |
clinical trial |
Statements
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia (English)
0 references
1 June 2006
0 references
11 October 2012
0 references
2,278
0 references
18 year
0 references